Effect of desmopressin acetate on bleeding times and plasma von Willebrand factor in Doberman pinscher dogs with von Willebrand's disease.
Effects of desmopressin acetate (1-desamino-8-D-arginine vasopressin [DDAVP]) on plasma von Willebrand factor (vWf) were studied in 12 purebred Doberman pinschers confirmed to have von Willebrand's disease (vWd) (plasma vWf antigen [vWf:Ag] concentrations, less than 30 U/dl). Twelve dogs had subnormal plasma botrocetin cofactor (BCf) activity and 11 dogs had prolonged buccal mucosa bleeding times. Tranquilization of three dogs with lenperone and three dogs with xylazine did not induce significant changes in mean plasma vWf:Ag concentrations or mean BCf activities. Thirty and 120 minutes after administration of DDAVP (1 micrograms/kg subcutaneously), there was significant shortening of the mean buccal mucosa bleeding time. Ten dogs responded to DDAVP with increases in BCf activity which exceeded 10 U/dl at 30 or 120 minutes, or both, after the drug was administered. At the same time, increases in plasma vWf:Ag concentrations were smaller than the increases in BCf activity. It was shown by multimeric analysis that primarily the higher molecular weight forms of vWf increased in plasma in response to DDAVP.
Kraus
K H
KH
Department of Veterinary Medicine, College of Veterinary Medicine, University of Missouri, Columbia 65211.
Turrentine
M A
MA
Jergens
A E
AE
Johnson
G S
GS
D000818:Animals; D001345:Autoradiography; D001760:Bleeding Time / Q000662:veterinary; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D003720:Densitometry; D004283:Dog Diseases / Q000097:blood* / Q000188:drug therapy; D004285:Dogs; D005260:Female; D008297:Male; D014842:von Willebrand Diseases / Q000097:blood / Q000188:drug therapy / Q000662:veterinary*; D014841:von Willebrand Factor / Q000032:analysis*
D014841:von Willebrand Factor; D003894:Deamino Arginine Vasopressin